Neuromuscular Disorder clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
- Non-Invasive Respiratory Monitor
- Applying pGz in Mitochondrial Disease
- Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- Northwestern Neuromuscular Disease Biorepository
- Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
- Measuring Physical Activity With ActivPal
- CIMR Neuromuscular Research Biobank
- Data Collection of Standard Care of Patients in the EMG Section
- Human Movement Database
- Molecular Analysis of Patients With Neuromuscular Disease
- Triple EIT (Electrical Impedance Tomography)
- Investigational Use of Neuromuscular Ultrasound
- Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
- Congenital Muscle Disease Study of Patient and Family Reported Medical Information
- Gamification Effects on the 6-Minute Walk Test in Children
- Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neuromuscular Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.